"Our goal at SK Life Science is to redefine seizure management by advancing research and education that translates into meaningful improvements for people living with epilepsy," said Louis Ferrari, BS ...
"Road to Reduction" Begins Airing Today Raising Awareness of XCOPRI ® (cenobamate tablets) CV and the Journey to Seizure Management for People Living with Epilepsy PARAMUS, N.J., May 19, 2025 ...
It’s boots on the ground, or rather in the office, for SK Life Science’s latest sales push aimed at getting its target, i.e., neurologists, to pay attention. The unconventional approach of “The Shoe ...
PARAMUS, N.J., Nov. 17, 2025 /PRNewswire/ -- SK Life Science, Inc., a global leader in treatments for central nervous system (CNS) disorders and a subsidiary of SK Biopharmaceuticals Co., Ltd., today ...
When SK Life Science began, it tapped into healthcare providers, patients, and scientists to ensure it was relentlessly focused on medical solutions to help drive success in treating central nervous ...
SK Life Science is inviting healthcare providers to literally put themselves in the shoes of patients with seizures—well, in a virtual way. The company's immersive “Step into Their Shoes” experience, ...
The ad is the latest DTC content from SK Life Science. Campaigns like this allow companies like SK Life Sciences to reach a patient population directly. This allows the message to be tailored to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results